questions for geoff cumming ado ceo session 3, page-70

Further to Sebs question.
Q: "When the introduction of M&G is adopted by POC1 for their device, would the protocols of the device demand that M&G is used in every test, or can the use of M&G be dependant on the ability to improve each individual test to be incorporated.
Ie. Does every test have to use M&G once POC1 signs with us".
End:

There is a big difference between being adopted on one test ie. troponin, or being adopted on every test from signing onwards.
Would also alter the importance of the decision for POC1 to determine whether to use us or not, and would alter the importance to ADO and shareholders.